- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01774214
Pediatric Fast Fluid Trial 2 (PFFT2)
October 26, 2013 updated by: Melissa J Parker, MD, MSc, McMaster Children's Hospital
Rapid Pediatric Fluid Resuscitation: a Randomized Controlled Trial Comparing the Efficiency of Two Provider-Endorsed Manual Fluid Resuscitation Techniques
The purpose of this study is to determine which of two commonly used methods of manual pediatric fluid resuscitation (The "Push-Pull Technique" vs. the "Disconnect-Reconnect Technique") allows for the most rapid administration of normal saline when this is urgently required.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
16
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8S4K1
- McMaster Children's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Health Care Providers working or training at McMaster Children's Hospital, including staff nurses, staff physicians, postgraduate medical trainees, nursing students, and medical students
- may be asked to perform manual fluid resuscitation as part of their clinical care activities
Exclusion Criteria:
- Inability to understand English
- Limited manual dexterity, specifically resulting in an inability to perform manual fluid resuscitation involving syringes
- Have acted in a physically strenuous capacity that may result in significant hand fatigue in the 30 minutes immediately prior to performance of the intervention. Where this is the only criteria limiting subject participation, rescheduling of an alternate testing time will be permitted.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: A
As this is a crossover trial, the study arms denote the order in which the two interventions are performed by the subject.
In Arm A, subjects will perform the "Push-Pull Technique" of manual fluid resuscitation first, followed by the "Disconnect-Reconnect Technique" second.
A washout period of at least 30 minutes between each of the two interventions will be observed.
|
Participants will administer 900 mL (60 mL/kg) of NS to a model of a 15 kg toddler in shock.
The intervention is the mode of administration of the fluid.
For the "Push-Pull Technique", the 7 cm catheter extension tubing will be connected to one of the three ports of a triple stopcock.
A second of the 3 ports of the triple stopcock will be connected to an IV tubing set connected to a 1 L bag of NS.
A 60 mL syringe will be connected to the third port of the triple stopcock.
On verbal prompt, participants will "pull" fluid from the bag of NS by withdrawing the plunger of the 60 mL syringe, filling it with saline.
They will then toggle the switch of the triple stopcock, so that it is "off" to the bag of NS and "open" to IV catheter extension tubing leading to the model.
They will then depress the syringe plunger, administering the fluid to the model.
These steps will be repeated until each participant believes that they have administered the requested volume of fluid to the model.
Participants will administer 900 mL (60 mL/kg) of NS to a model of a 15 kg toddler in shock.
The intervention is the mode of administration of the fluid.
For the "Disconnect-Reconnect Technique", the proximal end of the 7 cm catheter extension tubing will be capped with a needleless adapter.
The subject will be provided with 60 mL syringes filled with NS, rapidly prepared in real time by an assistant.
Syringes will be prepared by withdrawing NS from a 1 L bag via a Gambro Accessory spike.
The subject will administer the requested volume of NS to the model by 1. grabbing one of the fluid-filled syringes 2. connecting the fluid-filled syringe to the needleless adapter, and 3. depressing the syringe plunger resulting in administration of the NS to the model.
These steps will be repeated until the subject believes they have administered the requested volume of NS to the model.
Testing will begin on verbal prompt.
The subject and assistant will not be permitted to switch roles.
|
|
EXPERIMENTAL: B
As this is a crossover trial, the study arms denote the order in which the two interventions are performed by the subject.
In Arm B, subjects will perform the "Disconnect-Reconnect Technique" of manual fluid resuscitation first, followed by the "Push-Pull Technique" second.
A washout period of at least 30 minutes between each of the two interventions will be observed.
|
Participants will administer 900 mL (60 mL/kg) of NS to a model of a 15 kg toddler in shock.
The intervention is the mode of administration of the fluid.
For the "Push-Pull Technique", the 7 cm catheter extension tubing will be connected to one of the three ports of a triple stopcock.
A second of the 3 ports of the triple stopcock will be connected to an IV tubing set connected to a 1 L bag of NS.
A 60 mL syringe will be connected to the third port of the triple stopcock.
On verbal prompt, participants will "pull" fluid from the bag of NS by withdrawing the plunger of the 60 mL syringe, filling it with saline.
They will then toggle the switch of the triple stopcock, so that it is "off" to the bag of NS and "open" to IV catheter extension tubing leading to the model.
They will then depress the syringe plunger, administering the fluid to the model.
These steps will be repeated until each participant believes that they have administered the requested volume of fluid to the model.
Participants will administer 900 mL (60 mL/kg) of NS to a model of a 15 kg toddler in shock.
The intervention is the mode of administration of the fluid.
For the "Disconnect-Reconnect Technique", the proximal end of the 7 cm catheter extension tubing will be capped with a needleless adapter.
The subject will be provided with 60 mL syringes filled with NS, rapidly prepared in real time by an assistant.
Syringes will be prepared by withdrawing NS from a 1 L bag via a Gambro Accessory spike.
The subject will administer the requested volume of NS to the model by 1. grabbing one of the fluid-filled syringes 2. connecting the fluid-filled syringe to the needleless adapter, and 3. depressing the syringe plunger resulting in administration of the NS to the model.
These steps will be repeated until the subject believes they have administered the requested volume of NS to the model.
Testing will begin on verbal prompt.
The subject and assistant will not be permitted to switch roles.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall fluid infusion rate
Time Frame: From Date of Subject Randomization until Date Intervention Completed (Day 1)
|
Start Intervention Time is defined as the time that the model begins to effectively receive normal saline as administered by the participant, determined by the time at which fluid begins to collect in the graduated cylinder.
End Intervention Time is defined as the time at which the model ceases to effectively receive further normal saline as determined by the time at which fluid stops collecting in the graduated cylinder.
All testing will be videorecorded, with video reviews conducted by two independent and blinded outcome assessors using strict criteria to determine total intervention time (Total intervention time = end intervention time - start intervention time).
At the time of subject testing, the research assistant will also record the total amount of normal saline collected in the graduated cylinder at the end of the intervention.
Total intervention rate (mL/s) = volume of normal saline collected/Total intervention time.
|
From Date of Subject Randomization until Date Intervention Completed (Day 1)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accuracy of fluid volume delivery
Time Frame: From Date of Subject Randomization until Date Intervention Completed (Day 1)
|
Total volume of normal saline (mL) effectively administered to the model by the participant
|
From Date of Subject Randomization until Date Intervention Completed (Day 1)
|
|
Catheter dislodgement event while performing the intervention
Time Frame: From Date of Subject Randomization until Date Intervention Completed (Day 1)
|
Any IV catheter dislodgement events will be recorded by the research assistant at the time of subject testing on the data collection form.
The IV catheter is transfixed to the hand of the mannequin in typical clinical fashion.
The distal end of the catheter is located within conduit tubing which leads to a 1 litre graduated cylinder.
Connected to the proximal aspect (hub) of the IV catheter is a 7 inch long IV Catheter Extension set, which the participant will be in contact with as they administer the intervention.
|
From Date of Subject Randomization until Date Intervention Completed (Day 1)
|
|
Self-reported fatigue
Time Frame: From Date of Subject Randomization until Date Intervention Completed (Day 1)
|
Determined based upon responses to the study questionnaire which subjects will be asked to complete following performance of the intervention.
|
From Date of Subject Randomization until Date Intervention Completed (Day 1)
|
|
Fluid infusion rates for each of the three sequential fluid boluses
Time Frame: From Date of Subject Randomization until Date Intervention Completed (Day 1)
|
Bolus 1 rate = 300 mL/Time to effectively administer the first 300 mL of fluid; Bolus 2 rate = 300 mL/Time to effectively administer the second 300 mL of fluid; Bolus 3 rate = Remaining volume effectively administered beyond the first 600 mL/Time to administer this remaining volume.
Fluid administration times for Boluses 1, 2 and 3, will be determined based on video review in a similar fashion as for the Primary Outcome [Volume/(Bolus end time-Bolus start time)].
|
From Date of Subject Randomization until Date Intervention Completed (Day 1)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Melissa J Parker, MD, MSc, McMaster Children's Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Cole ET, Harvey G, Urbanski S, Foster G, Thabane L, Parker MJ. Rapid paediatric fluid resuscitation: a randomised controlled trial comparing the efficiency of two provider-endorsed manual paediatric fluid resuscitation techniques in a simulated setting. BMJ Open. 2014 Jul 3;4(7):e005028. doi: 10.1136/bmjopen-2014-005028.
- Cole ET, Harvey G, Foster G, Thabane L, Parker MJ. Study protocol for a randomised controlled trial comparing the efficiency of two provider-endorsed manual paediatric fluid resuscitation techniques. BMJ Open. 2013 Mar 21;3(3):e002754. doi: 10.1136/bmjopen-2013-002754.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2013
Primary Completion (ACTUAL)
May 1, 2013
Study Completion (ACTUAL)
May 1, 2013
Study Registration Dates
First Submitted
January 19, 2013
First Submitted That Met QC Criteria
January 19, 2013
First Posted (ESTIMATE)
January 23, 2013
Study Record Updates
Last Update Posted (ESTIMATE)
October 29, 2013
Last Update Submitted That Met QC Criteria
October 26, 2013
Last Verified
October 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12-358
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Shock
-
Assistance Publique - Hôpitaux de ParisTraumabase Group; Capgemini Invent; Ecole polytechnique; EHESS (Ecole des hautes... and other collaboratorsCompletedWounds and Injuries | Hemorrhagic Shock | Traumatic ShockFrance
-
Biomedizinische Forschungs gmbHMedical University of ViennaCompletedSepsis | Toxic-Shock Syndrome
-
Haukeland University HospitalMinistry of Defence, NorwayCompletedHemorrhagic Shock | Hypovolemic ShockNorway
-
King's College Hospital NHS TrustUniversity Hospital BirminghamCompletedTraumatic Haemorrhagic ShockUnited Kingdom
-
National Institute of Allergy and Infectious Diseases...Completed
-
Massachusetts General HospitalBeth Israel Deaconess Medical Center; Boston Medical Center; Tufts Medical Center and other collaboratorsRecruiting
-
Jason SperryNational Heart, Lung, and Blood Institute (NHLBI)TerminatedHemorrhagic ShockUnited States
-
University of Texas Southwestern Medical CenterUniversity of Washington; Resuscitation Outcomes ConsortiumCompletedHemorrhagic ShockUnited States
-
Ramathibodi HospitalUnknownSeptic Shock | Refractory ShockThailand
-
Arsenal Medical, Inc.RecruitingTrauma | Hemorrhagic Shock | Exsanguinating Hemorrhage | Shock; TraumaticUnited States
Clinical Trials on Push-Pull technique
-
University Hospital, GhentGhent University, BelgiumRecruitingPediatrics | Central Venous CatheterBelgium
-
McMaster UniversityCanadian Institutes of Health Research (CIHR)Completed
-
Chinese University of Hong KongNational Heart Centre SingaporeCompleted
-
Yale UniversityCompleted
-
Riphah International UniversityRecruitingAdhesive CapsulitisPakistan
-
Ain Shams UniversityRecruitingObstructed Labor at Second Stage of LaborEgypt
-
Loma Linda UniversityWithdrawnStomach Neoplasms | Pancreatic Cancer
-
Riphah International UniversityCompletedAdhesive CapsulitisPakistan
-
Kafrelsheikh UniversityCompleted
-
Hospital Universitario Insular Gran CanariaRecruiting